Portal Hypertension Mazen Hassanain.

Slides:



Advertisements
Similar presentations
Management of acute upper GI haemorrhage
Advertisements

POST-OPERATIVE COMPLICATIONS
CIRRHOSIS. Use of nonspecific has been studied extensively in randomized, controlled trials of the primary prophylaxis of variceal bleeding. β-adrenergic.
 Brian Torski, DO, Internal Medicine PGY-1.  Overview of Hepatorenal Syndrome o Pathophysiology o Diagnosis o Classification o Prevention and Treatment.
Acute Upper Gastrointestinal Hemorrhage “Surgical Perspective”
Varices Management: Current State of the Art Atif Zaman, MD MPH Associate Professor of Medicine Director of Clinical Hepatology Oregon Health & Science.
Teaching Liver cirrhosis with varices. Discussion  Approximately half of patients with cirrhosis have esophageal varices  One-third of all patients.
MAZEN HASSANAIN PORTAL HYPERTENSION. CAUSES Cirrhosis Non-cirrhosis.
 Treatment of malignant obstruction  Adjunct to surgery  Treatment of CBD calculi  Treatment of benign strictures  Diagnostic?  Failed ERCP.
Upper GI Bleeding Tad Kim, M.D. UF Surgery (c) ; (p)
UPPER GASTROINTESTINAL BLEEDING Bernard M. Jaffe, MD Professor of Surgery Emeritus.
Treatment of chronic liver disease. Treatment Cause ( Etiology) Cause ( Etiology) Complication Complication.
Hepatobiliary Anatomy and Pathology
Complications of Liver Cirrhosis Ayman Abdo MD, AmBIM, FRCPC.
Ayman Abdo MD, AmBIM, FRCPC
Liver pathology: CIRRHOSIS
Defining the Colorectal Surgeons role in patients with colorectal cancer and limited metastatic disease Jose G. Guillem, MD, MPH Department of Surgery.
- Definition: - Causes: 1.Liver cirrhosis (Com.). 2.Extra hepatic portal v. occlusion. 3.Intra hepatic veno occlusive Dis. 4.Occlusion of hepatic vein.
Results of minor and major hepatectomies by laparoscopy Brice Gayet, Vibert E, Kouider A Department of digestive pathology Montsouris Institute, Paris,
PORTAL HYPERTENSION & CHRONIC LIVER DISEASE SEAN CHEN ST GEORGE HEPATOBILIARY & PANCREATIC WORKSHOP 31/05/2014.
Neoadjuvant Adjuvant Curative Palliative Neoadjuvant Radiation therapy the results of a phase III study from Beijing demonstrated a survival benefit.
Core Topic UCI Internal Medicine Residency Learning Objectives Review the major causes of upper GI bleeding and important elements of the history.
Cirrhosis of Liver: Continuation Nursing 2015 Part two 22 to 42slides.
NYU Medical Grand Rounds Clinical Vignette Jeffrey Mayne, MD Third Year Resident Internal Medicine 1/17/2012 U NITED S TATES D EPARTMENT OF V ETERANS A.
TIPS on Portal Hypertension for Surgeons John R. Potts, III, M.D., F.A.C.S. Program Director in Surgery Assistant Dean Graduate Medical Education University.
Cholestatic liver diseases:
CASE PRESENTATION DR NADIA SHAFIQUE. CASE SUMMARY  38 yrs old female GULSHAN diagnosed case of HCV related DCLD (child class C) CTP score 11presented.
Portal Hypertension portal venous pressure > 5 mmHg
Transjugular Intrahepatic Portosystemic Shunt (TIPS) Presented by R2 吳佳展 2002/10/01.
PORTAL VEIN THROMBOSIS
Evaluating the Patient With Abnormal Liver Tests-2 פרופ ' צבי אקרמן מבית חולים הדסה הר הצופים.
INTERFERENCE TO NUTRITIONAL NEEDS DUE TO DEGENERATION AND INFLAMMATION Cirrhosis and Hepatitis.
PED17.  Caroli disease and caroli syndrome are congenital disorders to the intarhepatic bile ducts. They are both characterized by dilatation of the.
Interventional angiography Initial success rates for patients with acute peptic ulcer bleeding are between %, with recurrent bleeding rates of 10.
Long term maintenace of transjugular intrahepatic portosystemic shunt in children Case report Young Ju Hong M.D., Seonae Ryu, Hye Kyung Chang M.D., Jung.
Transjugular Intrahepatic Portosytemic Shunt Kevin A. Smith, MD Interventional Radiologist Roper Radiologists, PA.
Complications of liver cirrhosis
Pancreatic cancer.
Complications of liver cirrhosis
Gastroesophageal Varices Amreen M. Dinani MD, FRCPC VTSGNA Fall Conference October 24, 2015.
Interventional Radiology Radiology has provoked from providing purely diagnostic information to therapy, offering effective alternatives in the Rx.
Complications of Liver Cirrhosis
1 門診處方討論 Nadolol 用於 Gastrointestinal tract bleeding 的治療 報告者:蔡岱利
Ascites and Spontaneous Bacterial Peritonitis Arthur Harris, MD Attending, Division of Gastroenterology Jacobi Medical Center/North Central Bronx Hospital.
From Hemobilia to Hematochezia A 49-year-old woman transferred from an outside hospital because of severe hematochezia with a drop in hemoglobin from 14.
Portal Vein Thrombosis in Children and Adolescents
Journal Club Leona Isabella von Köckritz.
Medical Grand Round - Disease review
Complications of liver cirrhosis. Recognize the major complications of cirrhosis. Understand the pathological mechanisms underlying the occurrence of.
Liver mass Mazen Hassanain. Radiology Arterial enhancement: adenoma, FNH, hemangioma, HCC, NET mets Portal enhancement: CRC liver mets.
Radiology of hepatobiliary diseases
Liver Disease tutoring Part 2
Portal Hypertension.
Can argon plasma coagulation be endoscopic recovery treatment in uncontrolled esophageal varices bleeding? Hüseyin Sancar BOZKURT Gastroenterology,MD Medical.
History 24 Year old woman 6 Months of age “severe cholangitis’’ emergently decompressed via cholecystostomy tube choledochal cyst noted Definitive surgery:
Portal Hypertension.
A: Esophageal varices: Upper endoscopy demonstrates four columns of esophageal varices. A consequence of portal hypertension, esophageal varices are one.
GASTROENTEROLOGY 2009;137:892–901 R2. 정 회 훈.
COMPLICATIONS OF CIRRHOSIS
EUROPEAN LIVER TRANSPLANT REGISTRY
EUS-guided treatment of gastric fundal varices with combined injection of coils and cyanoacrylate glue: a large U.S. experience over 6 years (with video) 
Upper GI bleeding University of Jordan.
Proposed new acute variceal bleeding (AVB) management algorithm.
Andres Cardenas, Pere Ginès  Journal of Hepatology 
Internal medicine L-4 Liver cirrhosis & portal hypertension
Liver Cirrhosis ( 1 ) Prof. Mohamed Elhasafi, Hepatology Unit,
Douglas A. Simonetto, MD, Mengfei Liu, MD, Patrick S. Kamath, MD 
LIVER CIRRHOSIS IN PSC: DIAGNOSIS AND MANAGEMENT
Presentation transcript:

Portal Hypertension Mazen Hassanain

Causes Cirrhosis Non-cirrhosis

Asymptomatic Complications Symptoms Gastroesophageal varices Ascites Splenomegaly Underlying disease

Treatment of bleeding Initial therapy: hemodynamic resuscitation, prevention and treatment of complications Prophylactic antibiotics, preferably before endoscopy (although effectiveness has also been demonstrated when given after). Suggest intravenous ceftriaxone (1 g IV) or Cipro (400 mg IV BID) UGD should be performed for diagnosis and possible treatment Suggest terlipressin in countries where it is available and somatostatin or octreotide (50 mcg bolus followed by 50 mcg/hour by intravenous infusion) where terlipressin is unavailable

continue Salvage treatment TIPS (transjugular intrahepatic portosystemic shunt) Surgery is one with well preserved liver function who fails emergent endoscopic treatment and has no complications from the bleeding or endoscopy. The choice of surgery usually depends upon the availability, training, and expertise of the surgeon. Although a selective shunt has some physiologic advantages, it may significantly exacerbate marked ascites. Thus, a portacaval shunt would be preferable in patients with marked ascites

Shunt operations can be categorized as follows: Nonselective — those that decompress the entire portal tree, such as portacaval shunts Selective — those that compartmentalize the portal tree into a decompressed variceal system while maintaining sinusoidal perfusion via a hypertensive superior mesenteric-portal compartment, such as a distal splenorenal shunt Partial — those that incompletely decompress the entire portal tree and thereby also maintain some hepatic perfusion Nonshunt operations generally include either esophageal transection (in which the distal esophagus is transected and then stapled back together after varices have been ligated) or devascularization of the gastroesophageal junction (Sugiura procedure).

Maintain a hemoglobin of approximately 8 g/dL. Short-term (maximum seven days) antibiotic prophylaxis should be instituted in any patient with cirrhosis and GI hemorrhage. Pharmacologic therapy (somatostatin or its analogue octreotide) should start as soon as bleeding is suspected and continue for 3-5 days after confirmation. Upper endoscopy, performed within 12 hours, should be used to make the diagnosis and to treat variceal hemorrhage either with endoscopic variceal ligation or sclerotherapy. TIPS is indicated in patients in whom hemorrhage from esophageal varices cannot be controlled or in whom bleeding recurs despite combined pharmacological and endoscopic therapy. Balloon tamponade should be used as a temporizing measure (maximum 24 hours) in patients with uncontrollable bleeding for whom a more definitive therapy (eg, TIPS or endoscopic therapy) is planned.

Common Surgical problems Liver resection: Benign Hydatid cyst Abscess Large adenoma (5 cm) Intrahepatic biliary stones Oriental cholangiohepatitis Heamangioma Multiple cysts FNH Choledochal cyst Cystadenoma

Common Surgical problems Malignant Primary liver cancers HCC Cholangiocarcinoma Secondary liver cancers Colorectal cancer Neuroendocrine tumors Others (isolated, stable, chemo responsive)

Echinococcosis Disease Parasitic infection Oral treatment Surgical resection Biliary communication

HCC Cirrhosis Child A Non-cirrhosis Roles of resectability Survival benefit

Cholangiocarcinoma Resectability The role of bile ducts

CRC Metastasis Portal connection Survival benefit Limits of resection Increase resectability Decrease disease Increase volume Improve function

Liver transplant Cirrhosis HCV EToH NASH HCC Benign disease PBS